Tasigna and Valacyclovir hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tasigna (nilotinib hydrochloride monohydrate) and Valacyclovir hydrochloride (valacyclovir hydrochloride). Common drug interactions include cerebral venous thrombosis among females and graft versus host disease among males.

The phase IV clinical study analyzes what interactions people have when they take Tasigna and Valacyclovir hydrochloride. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Tasigna?

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 31,535 Tasigna users. Check the latest studies of Tasigna.

What is Valacyclovir hydrochloride?

Valacyclovir hydrochloride has active ingredients of valacyclovir hydrochloride. It is often used in herpes zoster. eHealthMe is studying from 12,929 Valacyclovir hydrochloride users. Check the latest studies of Valacyclovir hydrochloride.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

11 people who take Tasigna and Valacyclovir hydrochloride together, and have interactions are studied.

Tasigna and Valacyclovir hydrochloride drug interactions.

What are the common drug interactions of Tasigna and Valacyclovir Hydrochloride, by gender? *:

female:

Cerebral venous thrombosis (clot in brains venous blood system)

male:

Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Aphasia (damage to the parts of the brain that control language)
Pyrexia (fever)
Febrile neutropenia (fever with reduced white blood cells)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Arthralgia (joint pain)
Blood bilirubin increased
Cardiac arrest
Fatigue (feeling of tiredness)

What are the common drug interactions of Tasigna and Valacyclovir Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Nervous system disorder (a general class of medical conditions affecting the nervous system)

40-49:

n/a

50-59:

Cerebral venous thrombosis (clot in brains venous blood system)
Aphasia (damage to the parts of the brain that control language)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Cardiac arrest
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Malaise (a feeling of general discomfort or uneasiness)

60+:

Cell death
Cough
Gamma-glutamyltransferase increased
General physical health deterioration (weak health status)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Hyperhidrosis (abnormally increased sweating)
Inflammation
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Pyrexia (fever)

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 36.36%
B-Cell Type Acute Leukaemia (cancer of the white blood cells): 3 people, 27.27%
Furuncle (infection of the hair follicle): 2 people, 18.18%
Aplasia (defective development or congenital absence of an organ or tissue): 2 people, 18.18%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 18.18%
Pneumonia Pneumococcal (pneumococcal pneumonia is a common but serious infection and inflammation of the lungs): 1 person, 9.09%
Pain: 1 person, 9.09%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 9.09%
B Precursor Type Acute Leukaemia (lymphoid cancer): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Tasigna and Valacyclovir hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously